VAERS reports by lot

GSK Varicella/Shingles lot B334Y: VAERS reports

54 VAERS reports list lot B334Y as a GSK Varicella/Shingles vaccine, received between 2018-05-19 and 2022-12-08. Data: VAERS public files through 31 December 2024 (site extract 2026-07-04).

Read this first. VAERS accepts reports from anyone, and a report does not establish that the vaccine caused the event. A lot's report count mostly reflects how many doses it contained, when it was used and who received it; no administered-dose counts are published for this lot, so counts are not rates and cannot rank lots against each other. Lot numbers in VAERS reports are typed by reporters and are sometimes wrong.
54
Reports
6%
Marked serious
0
With a death outcome
9
Months with reports

Symptom categories in these reports

A report can mention several categories, so the counts add up to more than the number of reports.

CategoryCount%
General / Systemic (non-local)4527%
Injection-site / Local reaction3119%
Dermatological (non-injection-site)2817%
Musculoskeletal2213%
Cardiac / Cardiovascular106%
Neurological95%
Allergic / Anaphylactic74%
Gastrointestinal64%
Psychiatric / Neuropsychiatric32%
Respiratory21%
Autoimmune / Immune-mediated11%

Where reports came from

U.S. state of the reporter, where given (top 12).

California9
Oregon7
Virginia5
Massachusetts4
Arizona3
Florida3
Texas2
Washington2
North Carolina2
Minnesota2
Missouri2
New Mexico1

Reports by month received

2018-0510
2018-0627
2018-076
2018-085
2018-091
2018-102
2018-121
2021-021
2022-121

Products recorded with this lot

Manufacturer and product as reported in VAERS. Reports listing the lot under more than one product are counted once.

Related

Source: VAERS public data (CDC/FDA), grouped by manufacturer and lot by the Open Source Medicine Foundation; extract 2026-07-04 16:35 UTC. Not medical advice. Report errors via contact.